Page last updated: 2024-11-05

4-aminopropiophenone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4-aminopropiophenone: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID6270
CHEMBL ID3278330
SCHEMBL ID221282
MeSH IDM0094253

Synonyms (51)

Synonym
AC-16297
70-69-9
4'-aminopropiophenone
1-(4-aminophenyl)-1-propanone
p-aminopropiophenone
4-aminopropiophenone
wln: zr dv2
nsc-3187
propiophenone, 4'-amino-
nsc3187
1-propanone, 1-(4-aminophenyl)-
usaf uctl-1856
C13924
AE-641/00195035
ethyl p-aminophenyl ketone
propiophenone, 4-amino-
einecs 200-742-7
nsc 3187
paraminopropiophenone
brn 2802691
ai3-14675
1-(4-aminophenyl)propan-1-one ,
nsc-404994
nsc404994
NCIOPEN2_003525
A836965
bdbm81782
nsc_6270
cas_6270
AKOS005208691
STL280257
hsdb 7963
4-14-00-00139 (beilstein handbook reference)
79gf917w6u ,
unii-79gf917w6u
FT-0631305
1-propanone,1-(4-aminophenyl)-
SCHEMBL221282
CHEMBL3278330
1-(4'-aminophenyl)-propan-1-one
p-propionyl aniline
p-aminopropiophenone [mi]
para-aminopropiophenone
4-propionylaniline
DTXSID7021738
Q4637033
mfcd00017113
AS-19272
CS-0152655
EN300-116093
Z1203578051

Research Excerpts

Toxicity

ExcerptReferenceRelevance
") challenge with a 2 x LD50 dose (5."( Comparison of methemoglobin formers in protection against the toxic effects of cyanide.
Baskin, SI; Fricke, RF; Scharf, BA, 1992
)
0.28
" The period of persistence of PAPP baits may provide opportunities to improve the duration or longer term efficacy of baiting campaigns, but care is needed to protect domestic and working dogs to ensure responsible and safe use."( The longevity of para-aminopropiophenone (PAPP) wild dog baits and the implications for effective and safe baiting campaigns.
Allen, BL; Bell, K; Gentle, M; Haapakoski, H; Harris, S; Speed, J, 2017
)
0.46

Pharmacokinetics

ExcerptReferenceRelevance
" The pharmacodynamics were fit with an effect-compartment kinetic-dynamic model linked to a sigmoid Emax pharmacodynamic model."( Pharmacokinetics and kinetic-dynamic modelling of aminophenones as methaemoglobin formers.
Bredow, JV; Brewer, TG; Brown, LD; Lin, E; Marino, MT; Sperry, ML; Urquhart, MR, 1997
)
0.3

Bioavailability

ExcerptReferenceRelevance
" Bioavailability for all formulations varied between 20 and 47%."( Pharmacokinetics and kinetic-dynamic modelling of aminophenones as methaemoglobin formers.
Bredow, JV; Brewer, TG; Brown, LD; Lin, E; Marino, MT; Sperry, ML; Urquhart, MR, 1997
)
0.3

Dosage Studied

ExcerptRelevanceReference
" A dose-response relationship between benzocaine and MHb was investigated."( Topical anesthetic-induced methemoglobinemia in sheep: a comparison of benzocaine and lidocaine.
Guertler, AT; Lagutchik, MS; Martin, DG, 1992
)
0.28
"Oral dosing of rats with the cyanide antidote 4-aminopropiophenone (PAPP), brought about peak methaemoglobin levels at 15-40 min, but peak levels were attained at at 15-25 min after intravenous dosing."( The formation of methaemoglobin by 4-aminopropiophenone (PAPP) and 4-(N-hydroxy) aminopropiophenone.
Bright, JE; Inns, RH; Marrs, TC; Wood, SG, 1991
)
0.82
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1146770Competitive inhibition of Escherichia coli B H2-pteroate synthetase assessed as decrease in H2-pteroate formation using [7-14C]-PABA as substrate treated with enzyme for 10 mins prior to substrate challenge for 40 mins by radioassay method1977Journal of medicinal chemistry, Feb, Volume: 20, Issue:2
P-Aminobenzoic acid derivatives as inhibitors of the cell-free H2-pteroate synthesizing system of Escherichia coli.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (42)

TimeframeStudies, This Drug (%)All Drugs %
pre-199027 (64.29)18.7374
1990's8 (19.05)18.2507
2000's2 (4.76)29.6817
2010's4 (9.52)24.3611
2020's1 (2.38)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 32.71

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index32.71 (24.57)
Research Supply Index3.85 (2.92)
Research Growth Index4.39 (4.65)
Search Engine Demand Index40.78 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (32.71)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (2.17%)6.00%
Case Studies1 (2.17%)4.05%
Observational0 (0.00%)0.25%
Other44 (95.65%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]